| | Title | Authors / Editors | Date |
|
unige:155812 |
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer |
Addeo, Alfredo; Shah, Pankil K.; Bordry, Natacha; Hudson, Robert D.; ... Shah, Dimpy P. |
2021 |
|
unige:155814 |
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040 |
Harrington, Kevin J; Soulières, Denis; Le Tourneau, Christophe; Dinis, Jose; ... Cohen, Ezra E W |
2021 |
|
unige:155816 |
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial |
Rothschild, Sacha I.; Zippelius, Alfred; Eboulet, Eric I.; Savic Prince, Spasenija; ... Pless, Miklos |
2021 |
|
unige:155817 |
Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors |
Curigliano, Giuseppe; Gelderblom, Hans; Mach, Nicolas; Doi, Toshihiko; ... Naing, Aung |
2021 |
|
unige:154119 |
Local sustained GM-CSF delivery by genetically engineered encapsulated cells enhanced both cellular and humoral SARS-CoV-2 spike-specific immune response in an experimental murine spike DNA vaccination model |
Vernet, Rémi; Charrier, Emily Pauline; Cosset, Erika; Fievre, Sabine; ... Mach, Nicolas |
2021 |
|
unige:154147 |
Primary extra-osseous ewing sarcoma of the thyroid: a case report and review of the literature |
Seipel, Amanda; Mechahougui, Hiba; Mach, Nicolas; Triponez, Frédéric; ... De Vito, Claudio |
2021 |
|
unige:155815 |
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study |
Harrington, Kevin J.; Kong, Anthony; Mach, Nicolas; Chesney, Jason A.; ... Siu, Lillian L. |
2020 |
|
unige:155810 |
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01) |
Früh, Martin; Betticher, Daniel C.; Stupp, Roger; Xyrafas, Alexandros; ... Pless, Miklos |
2019 |
|
unige:155811 |
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study |
Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; ... Harrington, Kevin J |
2019 |
|
unige:155813 |
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08) |
Curioni-Fontecedro, Alessandra; Perentes, Jean Yannis; Gelpke, Hans; Xyrafas, Alexandros; ... Peters, Solange |
2019 |
|
unige:155809 |
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma |
Driessen, Christoph; Müller, Rouven; Novak, Urban; Cantoni, Nathan; ... Zander, Thilo |
2018 |
|
unige:93754 |
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial |
Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; ... Ochsenbein, Adrian F |
2017 |
|
unige:97068 |
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies |
Migliorini, Denis; Mach, Nicolas; Aguiar, Diego; Vernet, Rémi; ... Dietrich, Pierre-Yves |
2017 |
|
unige:93755 |
143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial |
Gautschi, Oliver; Li, Q; Matter-Walstra, K; Betticher, D; ... Ochsenbein, A |
2016 |
|
unige:90169 |
Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy |
Maesschalck, Thibault De; Dulguerov, Nicolas; Caparrotti, Francesca; Scolozzi, Paolo; ... Dulguerov, Pavel |
2016 |
|
unige:84846 |
Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature |
Sanchez, Andréa; Larousserie, Frédérique; Boudabbous, Sana; Beaulieu, Jean-Yves; ... Rougemont-Pidoux, Anne-Laure |
2016 |
|
unige:87954 |
Traitement des carcinomes épidermoïdes ORL chez la personne âgée |
Dulguerov, Nicolas; Caparrotti, Francesca; Mach, Nicolas; Dulguerov, Pavel |
2015 |
|
unige:155322 |
Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system |
Lathuiliere, Aurélien; Mach, Nicolas; Schneider, Bernard L |
2015 |
|
unige:90881 |
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma |
Hottinger, A F; Ben Aissa, Assma; Espeli, Vittoria; Squiban, D; ... Dietrich, Pierre-Yves |
2014 |
|
unige:26302 |
Role of the cytokine GM-CSF in cell-based anti-tumor immunity: learning from murine models to engineer new therapeutic strategies |
Mach, Nicolas |
2012 |
Mach, Nicolas
add all
remove all
